BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18272180)

  • 21. Activation of the luteinizing hormone/choriogonadotropin hormone receptor promotes ADP ribosylation factor 6 activation in porcine ovarian follicular membranes.
    Salvador LM; Mukherjee S; Kahn RA; Lamm ML; Fazleabas AT; Maizels ET; Bader MF; Hamm H; Rasenick MM; Casanova JE; Hunzicker-Dunn M
    J Biol Chem; 2001 Sep; 276(36):33773-81. PubMed ID: 11448949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A therapeutic chemical chaperone inhibits cholera intoxication and unfolding/translocation of the cholera toxin A1 subunit.
    Taylor M; Banerjee T; Navarro-Garcia F; Huerta J; Massey S; Burlingame M; Pande AH; Tatulian SA; Teter K
    PLoS One; 2011 Apr; 6(4):e18825. PubMed ID: 21526142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.
    Agren LC; Ekman L; Löwenadler B; Nedrud JG; Lycke NY
    J Immunol; 1999 Feb; 162(4):2432-40. PubMed ID: 9973526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guanine nucleotide dependent formation of a complex between choleragen (cholera toxin) a subunit and bovine brain ADP-ribosylation factor.
    Tsai SC; Adamik R; Moss J; Vaughan M
    Biochemistry; 1991 Apr; 30(15):3697-703. PubMed ID: 1901726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholera toxin action on rabbit corpus luteum membranes: effects on adenylyl cyclase activity and adenosine diphospho-ribosylation of the stimulatory guanine nucleotide-binding regulatory component.
    Abramowitz J; Campbell AR
    Biol Reprod; 1985 Mar; 32(2):463-74. PubMed ID: 3921075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity.
    Hong JX; Haun RS; Tsai SC; Moss J; Vaughan M
    J Biol Chem; 1994 Apr; 269(13):9743-5. PubMed ID: 8144566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication.
    Massey S; Banerjee T; Pande AH; Taylor M; Tatulian SA; Teter K
    J Mol Biol; 2009 Nov; 393(5):1083-96. PubMed ID: 19748510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state.
    Hong JX; Zhang X; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3056-9. PubMed ID: 7708774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of the cholera toxin A1 polypeptide from the endoplasmic reticulum to the cytosol is a rapid process facilitated by the endoplasmic reticulum-associated degradation pathway.
    Teter K; Allyn RL; Jobling MG; Holmes RK
    Infect Immun; 2002 Nov; 70(11):6166-71. PubMed ID: 12379694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADP-ribosylation by cholera toxin: functional analysis of a cellular system that stimulates the enzymic activity of cholera toxin fragment A1.
    Gill DM; Coburn J
    Biochemistry; 1987 Oct; 26(20):6364-71. PubMed ID: 3322378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of activation of cholera toxin by ADP-ribosylation factor (ARF): both low- and high-affinity interactions of ARF with guanine nucleotides promote toxin activation.
    Bobak DA; Bliziotes MM; Noda M; Tsai SC; Adamik R; Moss J
    Biochemistry; 1990 Jan; 29(4):855-61. PubMed ID: 2111167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of ADP-ribosylation factor by Golgi membranes. Evidence for a brefeldin A- and protease-sensitive activating factor on Golgi membranes.
    Randazzo PA; Yang YC; Rulka C; Kahn RA
    J Biol Chem; 1993 May; 268(13):9555-63. PubMed ID: 8486645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DD.
    Agren L; Norin M; Lycke N; Löwenadler B
    Protein Eng; 1999 Feb; 12(2):173-8. PubMed ID: 10195289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.
    Noda M; Tsai SC; Adamik R; Bobak DA; Moss J; Vaughan M
    Biochemistry; 1989 Sep; 28(19):7936-40. PubMed ID: 2514798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structural GDP/GTP cycle of human Arf6.
    Pasqualato S; Ménétrey J; Franco M; Cherfils J
    EMBO Rep; 2001 Mar; 2(3):234-8. PubMed ID: 11266366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cAMP-Independent Activation of the Unfolded Protein Response by Cholera Toxin.
    Banerjee T; Grabon A; Taylor M; Teter K
    Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33199355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholera toxin is exported from microsomes by the Sec61p complex.
    Schmitz A; Herrgen H; Winkeler A; Herzog V
    J Cell Biol; 2000 Mar; 148(6):1203-12. PubMed ID: 10725333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues.
    Eriksson AM; Schön KM; Lycke NY
    J Immunol; 2004 Sep; 173(5):3310-9. PubMed ID: 15322194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional modifications of transducin induced by cholera or pertussis-toxin-catalyzed ADP-ribosylation.
    Bornancin F; Franco M; Bigay J; Chabre M
    Eur J Biochem; 1992 Nov; 210(1):33-44. PubMed ID: 1332864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.